Rachel Zayas

Zayas has a Masters in Biotechnology and Business, previously launched a biotech venture and worked at MIT in cancer research developing gene silencing therapeutics using the RNA interference pathway. Zayas is currently a fellow for Healthworx (the investment arm of CareFirst BlueCross BlueShield), she has presented work at AASLD (liver disease conference) and published work in Hepatology. Zayas has written two fiction novels.